Table 1.

Summary of published hybrid revascularization studies

Author	Year	Method	N	Mortality (%)	PTCA/PCI restenosis (%, per patient)	Mean/median follow-up (month)	MACCE- free survival (%)
Angelini et al. [1]	1996	MidCAB/PTCA/PCI	6	0	n/r	n/r	n/a
Lloyd et al. [31]	1999	MidCAB/PTCA	18	0	6	18	89
Lewis et al. [32]	1999	MidCAB/PTCA/PCI	14	0	0	1.44	93
Zenati et al. [33]	1999	MidCAB/PCI	31	0	10	11	90
Wittwer et al. [34]	1999	MidCAB/PTCA/PCI	35	0	7	11	87
Isomura et al. [35]	2000	MidCAB/PTCA	37	0	n/r	24	92
De Canniere et al. [29]	2001	MidCAB/PTCA	20	0	5	24	95
Presbitero et al. [36]	2001	MidCAB/PTCA	42	2	14	18	83
Cisowski et al. [37]	2002	MidCAB/PTCA	50	0	10	12	87
Stahl et al. [38]	2002	MidCAB/PTCA	54	0	n/r	12	87
Riess et al. [39]	2002	MidCAB/PTCA	57	0	24	24	n/r
Lee et al. [40]	2004	TECAB/PCI	6	0	16	12	n/r
Davidavicius et al. [41]	2005	TECAB/PCI	20	0	0	19	100
Kiaii et al. [42]	2005	TECAB/PCI	1	0	0	6	100
Us et al. [43]	2006	MidCAB/PCI	17	0	18	21	87
Katz et al. [44]	2006	TECAB/PCI	10 BMS 17 DES	0	30 BMS 24 DES	3	67
Vassiliades et al. [45]	2006	TECAB/PCI	47 DES	0	6.6	7	90
Gilard et al. [46]	2007	MidCAB/PCI	70 DES	1.4	1.4	33	97
Kon et al. [47]	2008	MidCAB/PCI	15 DES	0	3	12	93
Bonatti et al. [48]	2008	TECAB/PCI	5 DES	0	0	6	100
Reicher et al. [49]	2008	MidCAB/PCI	13 DES	0	8	14	86
Holzhey et al. [50]	2008	TECAB/PCI	117	1.9	4.2	12	86
Zhao et al. [23]	2009	Transsternal CABG/PCI	87 DES 1 BMS 8 Both	2.6	11 BMS 5 DES	42	88
Halkos et al. [13•]	2011	EndoACAB	147 DES	0.7	3.4	38.4	86
Hu et al. [51]	2011	MidCAB/PCI	104	0	1.9 (n/r)	18	99
Rab et al. [11]	2012	MidCAB/PCI	22 DES	4.5	0	38.8	95
Leacche et al. [9••]	2012	MidCAB/PCI	80	5	N/A	1	91
Bachinsky et al. [10]	2012	Robotic MidCAB/PCI	25 (17 DES)	0	0	1	100
Fedakar et al. [12]	2012	OPCABG/PTCA/PCI	11*	0	0	0.5	100

MACCE: any death, stroke, MI, and/or revascularization/restenosis

^*Unknown type of stent